![Gwen A. Fyfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gwen A. Fyfe
Directeur/Membre du Conseil chez
Molecular Partners, Inc.
Profil
Gwen A. Fyfe is currently a Director at Molecular Partners, Inc. She previously served as a Director at Pharmacyclics LLC in 2010-2011, an Independent Director at Array BioPharma, Inc. in 2012-2019, a Director at Cascadian Therapeutics LLC in 2016-2018, an Independent Director at Infinity Pharmaceuticals, Inc. in 2012-2016, and a Vice President-BioOncology at Genentech, Inc. in 1997-2009.
She also served as an Independent Director at Igenica Biotherapeutics, Inc. and as a Director at Molecular Partners AG in 2017-2021.
Dr. Fyfe holds a doctorate degree from Washington University School of Medicine.
Postes actifs de Gwen A. Fyfe
| Sociétés | Poste | Début |
|---|---|---|
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Anciens postes connus de Gwen A. Fyfe
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur/Membre du Conseil | 21/04/2021 |
| ARRAY TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 30/07/2019 |
| CASCADIAN THERAPEUTICS INC (USA) | Directeur/Membre du Conseil | 09/03/2018 |
| INFINITY PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 17/06/2016 |
| PHARMACYCLICS, INC. | Directeur/Membre du Conseil | 30/06/2011 |
Formation de Gwen A. Fyfe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
